Global Clinical Nutrition Market Size was valued at USD 43.39 Billion in 2023. The Global Clinical Nutrition industry is projected to grow from USD 46.77 Billion in 2024 to USD 85.30 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 7.09% during the forecast period (2024 - 2032).
The surging prevalence of chronic conditions such as respiratory diseases, cancer, cardiovascular ailments, gastrointestinal disorders, and malnourishment among children and adults is elevating the requirement for nutritional support, the key market driver enhancing the market growth.
The growing prevalence of metabolic disorders, high spending on healthcare, and the increase of the middle class in emerging economies. Over the past decade, the majority of metabolic disorders have grown. For instance, the Gaucher’s Institute article modernized in November 2021 conveyed that Gaucher disease is equally prevalent in females and males and has a majority of 0.70 to 1.75 per 100,000 individuals. The same source also conveyed that the standardized birth incidence of Gaucher disease within the broad population ranges from 0.39 to 5.80 per 100,000 individuals. Such a burden of diseases completes the demand for clinical nutrition elements and thus drives the growth of the market. Clinical nutrition plays a significant part in minimizing patient adverse consequences and allowing surgeons to work in a controlled environment during surgeries. As per the Firm for Economic Co-operation and Development modernized in August 2022, the high number of surgeries (in thousand) executed in some European regions, including Portugal, Denmark, Ireland, and Norway, in 2021 include 94.87, 49.33, 32.84, 21.5. Thus, the rising burden of diseases and the volume of surgeries has enhanced the clinical nutrition market CAGR across the globe in recent years.
Moreover, product launches are a factor in market growth. For instance, in August 2021, Esperer Nutrition established a range of consumer nutraceuticals for joint health and bone, urinary tract health, immunity, sleep apnea, and pre-diabetic care. Such products introduced are expected to increase the adoption of clinical nutrition, increasing market growth over the forecast period. Hence, the increasing number of the elderly population and the establishment of clinical nutrition products specific to the aging population is expected to drive the growth of the clinical nutrition market revenue.
However, the growth ahead for clinical nutrition products represents a key opportunity for nutrition-focused brands. Glanbia Nutritionals’ customized premix solutions provide a way for them to simplify their internal processes. The company offers product application development, market knowledge, and high-quality bioactive ingredients to meet the needs.
The clinical nutrition market segmentation, based on type, includes infant, enteral, and parenteral nutrition. The parenteral nutrition segment held the majority share in 2022, contributing to the clinical nutrition market revenue. This is attributed owing to the rising prevalence of chronic disease and the rising geriatric population throughout the world. However, infant nutrition is the fastest-growing category over the forecast period. Infant nutrition is the term used to describe the dietary requirements of infants. An adequate diet provides sufficient calories, nutrients, vitamins, and fluids. Breast milk offers superior nutrition for these crucial first months of growth than infant formula has positively impacted market growth.
Figure 1 Clinical Nutrition Market by Type, 2022 & 2032 (USD billion)
Source Secondary Research, MRFR Database, Primary Research, and Analyst Review
The clinical nutrition market segmentation, based on application, includes cancer, metabolic disorders, gastrointestinal disorders, neurological disorders, and others. The cancer segment held the majority share in 2022, contributing to the clinical nutrition market revenue. This is owing to the increase in the number of people suffering from chronic conditions, including cancer and diabetes, coupled with a growing geriatric population base, which is expected to drive the market over the forecast period. However, metabolic is the fastest-growing category over the forecast period due to rising incidences of chronic diseases that have produced growth in clinical nutrition medications as patients suffering from such conditions are denied of few essential nutrients. Moreover, the increasing obese population due to unhealthy dietary habits and physical inactivity will propel the industry growth.
By Region, the study delivers market insights into North America, Europe, Asia-Pacific, and the Rest of the World. The North America clinical nutrition market accounted for USD 4.16 billion in 2022 and is expected to exhibit a significant CAGR growth over the study period. This is attributed to the rising number of manufacturers that have increased production and are working with retailers and government agencies to assist in ensuring adequate availability of and continued access to oral clinical nutrition products. Some of the major factors owing to the growth of the clinical nutrition market include an enhancement in the prevalence of metabolic disorders. For instance, according to a press release by the government of Canada issued in August 2021, diabetes is one of the prominent chronic diseases impacting Canadians where around 3 million Canadians, or 8.8% of the people, were analyzed with diabetes, and 6.1% of Canadian adults were at huge risk of developing diabetes. Such diseases require long-term clinical nutritional support. Thus, diseases, including diabetes, are expected to boost market growth over the forecast period.
Further, the major countries studied in the market report are The U.S, Canada, Germany, the UK, Italy, Spain, France, China, Japan, India, Australia, South Korea, and Brazil.
Figure 3 CLINICAL NUTRITION MARKET SHARE BY REGION 2022 (%)
Source Secondary Research, MRFR Database, Primary Research, and Analyst Review
Europe clinical nutrition market accounts for the second-largest market share due to the presence of key players in the market has also been a factor in the large share of the revenue. Further, the Germany clinical nutrition market held the largest market share, and the UK clinical nutrition market was the fastest-growing market in the European region.
The Asia-Pacific clinical nutrition market is expected to grow at the fastest CAGR from 2024 to 2032. Malnutrition and food insecurity are major problems in the Asia-Pacific region. A healthy diet was out of reach for about 1.9 billion people in the area. About half of the world's undernourished people in 2019 lived in the Asia-Pacific region. According to a press release on UNICEF's website, an estimated 74.5 million are stunted (too short for their age), and 31.5 million are wasting children under five throughout the region. Moreover, China clinical nutrition market held the largest market share, and the India clinical nutrition market was the fastest-growing market in the Asia-Pacific region.
Major market players are spending a huge amount of money on R&D to enhance their product lines, which will assist the clinical nutrition market to grow even more. Market players are also taking several strategic initiatives to grow their footprint ly. Key market developments include new product establishment, contractual agreements, mergers and acquisitions, enhanced investments, and collaboration with other organizations. Competitors in the clinical nutrition industry must provide cost-effective items to enhance and survive in an increasingly competitive and improved market environment.
Manufacturing locally to reduce operating costs is one of the major business strategies manufacturers adopt in the clinical nutrition industry to benefit clients and expand the market sector. In the healthcare, big data analytics market, major players such as Solace Nutrition (U.K.), AYMES Nutrition International Ltd. (U.K.), Mead Johnson and Company LLC. (U.S.), and others are working on enhancing the market demand by investing in R&D activities.
Tate & Lyle PLC (Tate & Lyle) provides food and beverage solutions and ingredients. The company's product portfolio comprises sweeteners, restaurants, and fiber enrichments. It also provides crystalline fructose, sucralose, sweeteners, starches, corn syrup, dextrose, glucose, and animal feeds. In February 2021, Tate & Lyle PLC (Tate & Lyle) launched the Tate & Lyle Nutrition Centre. This new digital hub provides easy access to authoritative science on ingredients that can help address public health challenges. The Tate & Lyle Nutrition Centre's mission is to raise awareness of evidence-based science for ingredients such as low- and no-calorie sweeteners and dietary fibers and their role in a healthy, balanced diet. The hub, accessed at www.tateandlyle.com/nutrition-centre, contains expert insights, research, and educational tools for food and beverage companies, scientists, and health professionals.
Also, Galen Ltd. manufactures and distributes pharmaceuticals. The Company markets generic and brand-name drugs throughout the United Kingdom and Ireland. In February 2020, Galen launched PKU EASY Microtabs for the phenylketonuria condition, which contain protein substitutes to help manage the protein intake they need. This launch would help to expand the product portfolio and business of the company's nutritional therapies.
June 2022 The world's top virtual research organization (VRO), ObvioHealth, has a wealth of clinical, pharmaceutical, biotechnology, and healthcare experience6. It is building ground-breaking end-to-end solutions for remote clinical trials. Announced the creation of an advisory council made up of significant business figures.
| Report Attribute/Metric | Details |
| Market Size 2023 | USD 43.39 billion |
| Market Size 2024 | USD 46.77 billion |
| Market Size 2032 | USD 85.30 billion |
| Compound Annual Growth Rate (CAGR) | 7.09% (2024-2032) |
| Base Year | 2023 |
| Market Forecast Period | 2024-2032 |
| Historical Data | 2018 - 2022 |
| Market Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Growth Factors, Market Competitive Landscape, and Trends |
| Segments Covered | Type, Application, and Region |
| Geographies Covered | North America, Europe, Asia Pacific, and the Rest of the World |
| Countries Covered | The U.S, Germany, Canada, France, Italy, Spain, the UK, China, Japan, South Korea, India, Australia, and Brazil |
| Key Companies Profiled | Solace Nutrition (U.K.), AYMES Nutrition International Ltd. (U.K.), Braun Melsungen AG (Germany), NeoMed (U.S.), Abbott Nutrition (U.S.), Baxter International (U.S.), Danone (France), and others |
| Key Market Opportunities | The increase in capital investments by the healthcare industry in the IT sector |
| Key Market Dynamics | The increasing prevalence of metabolic disorders. high spending on healthcare The increase of the middle class in emerging economies. |
Frequently Asked Questions (FAQ) :
The Clinical Nutrition market size was valued at USD 43.39 Billion in 2023.
The market is projected to grow at a CAGR of 7.09% during the forecast period 2024-2032.
North America had the largest share of the market.
The key players in the market are Solace Nutrition (U.K.), AYMES Nutrition International Ltd. (U.K.), Braun Melsungen AG (Germany), NeoMed (U.S.), Abbott Nutrition (U.S.), Baxter International (U.S.), Danone (France), and others.
The parenteral nutrition category dominated the market in 2023.
The cancer category dominated the market in 2023.
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
